Hahn & Company and Lutronic CEO Haelyung Hwang Launch Tender Offer to Acquire Lutronic
June 14, 2023
South Korean private equity firm Hahn & Company has signed definitive agreements with Lutronic founder and CEO Haelyung Hwang to jointly launch a tender offer for all remaining shares of Lutronic for KRW957.0 billion (US$735.9 million). Lutronic is a South Korea–based maker of aesthetic medical devices with 2022 revenues of over KRW264 billion and a growing global presence, particularly in the United States and Europe.
- Buyers
- Hahn & Company, Haelyung Hwang
- Targets
- Lutronic
- Industry
- Medical Devices
- Location
- South Korea
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
San'an Optoelectronics and Inari Amertron to Acquire Lumileds Holding B.V.
August 1, 2025
Manufacturing
San'an Optoelectronics and Inari Amertron Berhad have entered into a definitive agreement to acquire 100% of Lumileds Holding B.V. and its European and Asian subsidiaries (Lumileds International). The transaction is expected to close by the first quarter of 2026, subject to customary closing conditions.
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Hahn & Company Acquires Cynosure and Merges It with Lutronic to Form Cynosure Lutronic
January 19, 2024
Medical Devices
Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.
-
Platinum Equity Acquires Majority Interest in Hop Lun
June 20, 2022
Manufacturing
Platinum Equity has acquired a controlling stake in Hong Kong-headquartered lingerie and swimwear manufacturer Hop Lun from founder Erik Ryd, who retained a significant ownership stake. The transaction, led by Platinum's Singapore investment team, positions Hop Lun — a global designer and manufacturer employing over 30,000 with production in Bangladesh, China, Ethiopia and Indonesia — for accelerated organic growth, strategic M&A and sustainability initiatives. Financial terms were not disclosed.
-
Hahn & Co. and Hana Financial Group Buy H-Line Shipping for 1.8 Trillion Won
May 24, 2020
Transportation
South Korea’s private equity firm Hahn & Co. and Hana Financial Group have agreed to buy a 100% stake in H-Line Shipping for 1.8 trillion won (~$1.45bn). The deal is structured as a leveraged buyout via a project fund (about 45% financed with debt) and is intended to move the shipping company’s ownership to long-term investors while supporting consolidation and growth in Hahn & Co.’s shipping platform.
-
ALPHAEON Acquires LENSAR
November 16, 2015
Medical Devices
ALPHAEON Corporation has agreed to acquire substantially all assets of LENSAR, Inc. in a transaction valued at up to $59 million in cash, stock and assumed debt. The deal brings LENSAR’s femtosecond cataract laser technology into ALPHAEON’s lifestyle healthcare portfolio and expands ALPHAEON’s ophthalmology offering for its global network of ophthalmologists.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.